Winter survival: Brain peptide called corazonin stops bug reproduction
Peer-Reviewed Publication
Updates every hour. Last Updated: 18-Oct-2025 23:11 ET (19-Oct-2025 03:11 GMT/UTC)
As the days grow shorter, many animals prepare for the approaching winter by suspending reproduction. Insects, for example, accumulate energy stores while halting ovarian development through a process known as reproductive diapause. In a recent study published in The Journal of Experimental Biology, researchers at The University of Osaka uncovered a key neuroendocrine pathway underlying this seasonal shift in the bean bug Riptortus pedestris, identifying the neuropeptide corazonin as a molecular signal that suppresses reproduction in response to changes in day length.
The age at which a woman has her first period can offer valuable clues about her long-term risk for conditions like obesity, diabetes, heart disease and reproductive health issues, according to a study being presented Sunday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.
In biology textbooks and beyond, the human genome and DNA therein typically are taught in only one dimension. While it can be helpful for learners to begin with the linear presentation of how stretches of DNA form genes, this oversimplification undersells the significance of the genome’s 3D structure. Problems with this 3D structure are associated with many diseases including developmental disorders and cancer.
Scientists at Sanford Burnham Prebys and colleagues in Hong Kong published findings June 27, 2025, in Genome Biology demonstrating a new approach for better understanding the human genome’s 3D structure and its influence.A team of researchers in France are building on fundamental experimental research undertaken in the Ukrainian Chornobyl exclusion zone with a new project in the Japanese Fukushima Prefecture to further our understanding of what it means for animals to live and reproduce in radioactive environments.
SUTD researchers leveraged their expertise in microfluids to develop a novel method for deforming cells mechanically to facilitate intracellular delivery, revolutionising personalised treatments at the cellular level. SUTD researchers leveraged their expertise in microfluids to develop a novel method for deforming cells mechanically to facilitate intracellular delivery, revolutionising personalised treatments at the cellular level.